ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,220.90
0.24%
S&P ASX All Technology
3,825.10
-0.11%
Brent Oil
73.285
0.00%
US Dollar vs AUD
1.60312
0.03%
Bitcoin
98,097.82
-0.59%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Arkema (AKE) Share Price

Arkema

Arkema (AKE)

Allkem Ltd
Atlas Cloud Enterprises Inc
Alikem Limited
71.00
0.30
(0.42%)
Closed 25 December 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
71.00
Bid
70.95
Offer
71.35
Volume
52,605
70.75 Day's Range 71.80
69.15 52 Week Range 104.40
Market Cap
5.304B
Previous Close
70.70
Open
70.75
Last Trade
101
@
71
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
184,220
Shares Outstanding
74,704,751
Dividend Yield
4.93%
PE Ratio
12.69
Earnings Per Share (EPS)
5.6
Revenue
9.55B
Net Profit
418M

About Arkema

Sector
Chemicals & Chem Preps, Nec
Industry
Chemicals & Allied Products
Website
www.arkema.com
Headquarters
Colombes, Hauts-de-seine, Fra
Founded
2003
Arkema is listed in the Chemicals & Chem Preps sector of the Euronext with ticker AKE. The last closing price for Arkema was 70.70 €. Over the last year, Arkema shares have traded in a share price range of 69.15 € to 104.40 €.

Arkema currently has 74,704,751 shares in issue. The market capitalisation of Arkema is 5.28 € billion. Arkema has a price to earnings ratio (PE ratio) of 12.69.

Ask ADVFN Intelligence (AI)

AKE Latest News

More News

Arkema Achieves a Milestone in Its Coating Products Portfolio Carbon Footprint Reduction with the Launch of Global Mass Balance Solutions for All Coatings Technologies

PARIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Arkema, a leader in Specialty Materials, set the groundwork for carbon footprint reduction across its Coating Solutions value chain in 2024, with a...

20 December 2024
GlobeNewswire Inc.

ARKEMA : RÉSULTATS DU 1ER TRIMESTRE 2022

Regulatory News: Arkema (Paris:AKE) a réalisé une excellente performance financière au premier trimestre, malgré la forte inflation des matières premières et de l’énergie et une certaine...

05 May 2022
Business Wire

Arkema: Information Relating to the Combined Annual General Meeting of 19 May 2022

Regulatory News: Arkema (Paris:AKE): Arkema’s shareholders are invited to participate in the combined annual general meeting, which will be held on Thursday 19 May 2022 at 10 a.m. (Paris time...

30 April 2022
Business Wire

ARKEMA : Déclaration relative au nombre total de droits de vote et d’actions prévue par l’article L.233-8 II du Code de commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers

Regulatory News: ARKEMA (Paris:AKE) : A la date du Nombre d’actions composant le capital Nombre théorique des droits de vote (y compris actions auto-détenues) Nombre réel de droits de...

05 April 2022
Business Wire

Mise à disposition du document d’enregistrement universel 2021 d’arkema

Regulatory News: Arkema (Paris:AKE) annonce la publication de son Document d’enregistrement universel 2021. Le Document d’enregistrement universel 2021 a été déposé auprès de l’Autorité des...

30 March 2022
Business Wire

Arkema : Déclaration des transactions sur actions propres réalisées du 07 mars au 11 mars 2022

Regulatory News: Conformément à la réglementation applicable, Arkema (Paris:AKE) déclare avoir effectué les opérations d'achat d'actions suivantes dans les conditions de l'article 5 §2 du...

15 March 2022
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.95-2.6730637422972.9573.8569.1520541571.36036607DE
4-6.3-8.1500646830577.37969.1519778474.36892272DE
12-14.7-17.152858809885.788.269.1518422078.48542019DE
26-12.8-15.274463007283.888.469.1516091380.23487372DE
52-30.75-30.2211302211101.75104.469.1515030687.13002616DE
156-48.5-40.5857740586119.5134.9569.1515958792.57551064DE
260-24.62-25.747751516495.62134.9542.518124492.53916488DE

AKE - Frequently Asked Questions (FAQ)

What is the current Arkema share price?
The current share price of Arkema is 71.00 €
How many Arkema shares are in issue?
Arkema has 74,704,751 shares in issue
What is the market cap of Arkema?
The market capitalisation of Arkema is EUR 5.28B
What is the 1 year trading range for Arkema share price?
Arkema has traded in the range of 69.15 € to 104.40 € during the past year
What is the PE ratio of Arkema?
The price to earnings ratio of Arkema is 12.69
What is the cash to sales ratio of Arkema?
The cash to sales ratio of Arkema is 0.56
What is the reporting currency for Arkema?
Arkema reports financial results in EUR
What is the latest annual turnover for Arkema?
The latest annual turnover of Arkema is EUR 9.55B
What is the latest annual profit for Arkema?
The latest annual profit of Arkema is EUR 418M
What is the registered address of Arkema?
The registered address for Arkema is 420, RUE D'ESTIENNE D'ORVES, COLOMBES, HAUTS-DE-SEINE, 92705
What is the Arkema website address?
The website address for Arkema is www.arkema.com
Which industry sector does Arkema operate in?
Arkema operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EIFDSTour Eiffel DS
0.0432 €
(800.00%)
89.74k
SEQUASequana medical NV
2.76 €
(33.33%)
1.64M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
ALPAUPaulic Meunerie SA
1.43 €
(16.26%)
17.14k
GNROGeNeuro SA
0.081 €
(15.38%)
330.33k
MLSMLSmalto
0.0125 €
(-32.43%)
50
ALVIAVialife Sa
13.30 €
(-27.72%)
7
MLMADMade
9.25 €
(-15.91%)
255
ALALOAcheterLouerFR
0.23 €
(-14.81%)
3.92k
ALLPLLepermislibre SA
0.397 €
(-11.78%)
3.01k
ATOAtos SE
0.0023 €
(-4.17%)
396.59M
BCPBanco Comercial Portugues SA
0.451 €
(0.16%)
17.85M
LATLatecoere
0.0094 €
(3.30%)
9.13M
ALVERVergnet
0.0021 €
(-4.55%)
8.37M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M

Discussion

View Full Feed
Steady_T Steady_T 8 minutes ago
Merry Christmas and Happy Chanukah to all.

Thank you Paulie for some great laughter this year.
AugustaFriends AugustaFriends 16 minutes ago
Stocks ... the batteries.

$FREY $SLDP $MVST $EOSE $QS $SES $LCID $ABAT
ABAT EOSE FREY
nowwhat2 nowwhat2 24 minutes ago
24/7/365 - Ho ! Ho ! Ho !


https://investorshub.advfn.com/uimage/uploads/2024/12/25/u[ewzBTC_121212_24_2d_1030pm_SANTA.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/24/goyylbtc_121212_24_45d_830pm_DIAG_HORIZ.jpg

BTCUSD
sam1933 sam1933 28 minutes ago
YW [yt]ThZbfQb6CU0[/yt]
HBARUSD
Top Penny Top Penny 41 minutes ago
Merry Christmas Bill! You are golden!
MONI
ReasearchThis ReasearchThis 43 minutes ago
AXXA Basher puts 200 shares of AXXA up for sale at .0008
Then from a different account puts in an order to buy 200 shares of AXXA For .0008 imagine that. Or visa versa.

Why would anyone want a $1++ eventually a $5 to $20 a share stock to be trading for less than a penny?
AXXA
MasterBlastr MasterBlastr 45 minutes ago
Don't worry. He will be punked, stonewalled, litigated, and deep-stated at every turn unit he is driven back into his hole.
lovethatgreen lovethatgreen 50 minutes ago
If korenko had presence of mind to share with his shareholders the status and true location of the human trials being in India, possibly a lot of the tax loss selling would have been avoided . But , he chose not to share which in my opinion is inexcusable.

I know the expectation for
RDGL
Diamond_Dog Diamond_Dog 52 minutes ago
MERRY CHRISTMAS EVERYONE......

D_DOG
DP1011 DP1011 54 minutes ago
I can't wait to see all of this loan money in the next Q. Only 40 days away. 🙄 

Your not gonna see it.... these loans are like John Cena. 🤓🤣
PHIL
PlaySmart2020 PlaySmart2020 58 minutes ago
$RDAR potential way to NASDAQ (Patience will pay off)
RDAR
camelion camelion 1 hour ago
Agree! Also DTC shares were not accounted on the daily. Shady biz between MMG & TA
DTC
JJ8 JJ8 1 hour ago
Vectorvest Report/Analysis:

INDUSTRY GRAPH (3 months)

VECTORVEST SUMMARY
NVDA is currently undervalued, has well above average safety, and is currently rated a Hold.

RECOMMENDATION
NVDA is currently rated a Hold.


VAL
NVDA
PlaySmart2020 PlaySmart2020 1 hour ago
Happy Christmas to all, enjoy the festive and don't forget $HMBL would be a next year treat!
HMBL
nowwhat2 nowwhat2 1 hour ago
Mr. MSTR, etc.



https://www.youtube.com/watch?v=8Perx7nXXiE



re : Todays' Santa Rally

https://www.youtube.com/watch?v=5a6hET2OR3k

Tuesday Dec. 24
https://investorshub.advfn.com/uimage/uploads/2024/12/24
MSTR
wallstreet1231 wallstreet1231 1 hour ago
Good points. I still think patience will pay off here.
CNNA
Coppermine Coppermine 1 hour ago
Only new bees don’t know when the ticker changes, anyone holding shares can’t trade for 30 days. So yes, please change the ticker symbol.
CGAC
Canna_Business Canna_Business 2 hours ago
MRMD: MariMed Inc.
Low Debt for Financial Stability: MRMD operates with minimal debt, ensuring sustainable growth and resilience in a rapidly changing market. The price is low compared to the number of shares outstanding with limited dilution.

Proven Expertise with Medical Lice
CVS MRMD
Canna_Business Canna_Business 2 hours ago
MRMD: MariMed Inc.
Low Debt for Financial Stability: MRMD operates with minimal debt, ensuring sustainable growth and resilience in a rapidly changing market. The price is low compared to the number of shares outstanding with limited dilution.

Proven Expertise with Medical Lice
CVS MRMD
Canna_Business Canna_Business 2 hours ago
MRMD: MariMed Inc.
Low Debt for Financial Stability: MRMD operates with minimal debt, ensuring sustainable growth and resilience in a rapidly changing market. The price is low compared to the number of shares outstanding with limited dilution.

Proven Expertise with Medical Lice
CVS MRMD
alertmeipp alertmeipp 2 hours ago
FWIW - ChatGPT on appeal chances - quick summary is it would be a uphill battle.

Enanta’s chances on appeal will depend on its ability to challenge the district court’s key rulings regarding **priority date determination** and **anticipation**. Here’s an analysis of its prospects:
ENTA
Sammy boy Sammy boy 2 hours ago
I believe Trump owned FNMA and had to sell when he became # 45. Daddy knows the story !
FNMA
janice shell janice shell 2 hours ago
This year's message from Joe Biden:

https://x.com/JoJoFromJerz/status/1871767198668308484

Your Recent History

EU
AKE
Arkema
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads